TD Cowen Initiates Coverage On Korsana Biosciences with Buy Rating
TD Cowen analyst Tyler Van Buren initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating.
Share
Why It Matters
A big investment bank analyst started following Korsana and thinks it looks good. When new experts start watching a company, it means they see something worth paying attention to.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.